LLY stock, Novo Nordisk to dominate Obesity despite Amgen entry (NYSE:LLY)
Hailshadow/iStock via Getty Images Bank of America argues that Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) (OTCPK:NONOF) are “undisputable leaders” in the market for obesity and diabetes therapeutics despite encouraging Phase 1 data…